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expression of glucocorticoid and angio-
tensin II receptors and tumor necrosis 
factor-α, but this could all be secondary 
to renal injury. Accumulation of extracel-
lular matrix within the kidney may also 
play a role, as obesity has been shown 
to induce accumulation of hyaluronan 
in the renal medulla of dogs and rab-
bits. External compression of the kidney 
by visceral fat may increase interstitial 
hydrostatic pressure or induce ischemia. 
Such physical changes could also enhance 
sympathetic activity in obesity.10
Apparently, sheep and other ungulates 
have adapted to pregnancy in winter 
when conditions are harsh and nutrients 
scarce. At high altitudes, nutrient restric-
tion and a harsh climate are compounded 
by hypoxia (Figure 1). One aspect of this 
adaptation is undoubtedly the building 
up of reserves in the summer in combi-
nation with a lot of movement all year 
round. A surfeit of nutrients during 
intrauterine life apparently interferes 
with this cycle and caused these sheep 
to lose some unknown protective factor, 
the resulting injury subsequently being 
triggered by obesity. However, in our 
opinion, this peculiar ovine maladjust-
ment is not the most important point of 
the study. 
What is of importance is that, dur-
ing evolution, matching of perina-
tal, juvenile, and adult conditions has 
apparently been a powerful selective 
force.11 Because nowadays life expect-
ancy exceeds our reproductive age and 
modern lifestyle includes excessive cal-
orie and sodium intake, a mismatch of 
these conditions is increasingly appar-
ent and can enhance susceptibility to a 
host of diseases.9,11 Th e observations by 
Williams et al.8 stress that with today’s 
knowledge it remains hard to predict 
the outcome of a specifi c developmental 
perturbation. Clearly, the mechanisms 
remain shrouded but may well include 
metabolic eff ects on genetic imprinting 
that cause persistent eff ects long aft er 
early development.
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Pro-resolution properties of 
macrophages in renal injury
DC Kluth1
Macrophages are inflammatory cells with important roles in the 
propagation of renal injury. More recently they have also been shown 
to be important in the resolution of inflammation. Wang et al. show 
that macrophages can be modulated ex vivo by cytokine stimulation, 
localize to renal tissue, and slow progression of experimental 
glomerular inflammation. Thus strategies targeting macrophage 
function have considerable therapeutic potential.
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Introduction
Macrophage infi ltration is a nearly uni-
versal feature of glomerular injury in both 
human and experimental disease, and the 
presence of macrophages is associated 
with progression to renal failure regard-
less of initiating insult. In general, these 
infl ammatory cells were considered to be 
activated by proinfl ammatory cytokines 
such as tumor necrosis factor-α (TNF-α) 
and interferon-γ and to develop proper-
ties injurious to the kidney. However, it 
has become increasingly clear that macro-
phages are part of a regulated infl amma-
tory system that not only initiates injury 
but is also involved in its resolution.
Wang and colleagues1 (this issue) pro-
vide further evidence of the potential for 
macrophages to have benefi cial eff ects 
in renal injury. Th ey demonstrate that 
in murine adriamycin nephropathy (a 
model of chronic glomerular inflam-
mation), injection of macrophages 
stimulated with the ‘anti-infl ammatory’ 
cytokines interleukin (IL)-4 and IL-
13 reduces the severity of injury for up 
to 3 weeks aft er the injection, whereas 
administration of lipopolysaccharide-
activated macrophages worsens disease. 
Th is further supports the concept that 
administered macrophages may have a 
dominant regulatory eff ect.
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Proinflammatory properties of  macro-
phages
Evidence has established a role for 
macrophages in the propagation of 
infl ammation. Th e importance of proin-
fl ammatory cytokines such as TNF-α, 
IL-1β, interferon-γ, and IL-12 in the 
development of glomerulonephritis 
(GN) is well known, and they all have 
the potential to activate macrophages. 
These, in turn, produce a number of 
potentially cytotoxic products (includ-
ing proteolytic enzymes, reactive oxygen 
species, eicosanoids, proinflamma-
tory cytokines, and chemokines), thus 
amplifying the infl ammatory response. 
This has been confirmed in animal 
models of GN, in which isolated mac-
rophages show enhanced production of 
a range of proinfl ammatory mediators, 
including nitric oxide, reactive oxy-
gen species, and TNF-α. Furthermore, 
macrophages isolated from glomeruli of 
rats with nephrotoxic nephritis (NTN) 
behave operationally as if activated by 
interferon-γ and do not respond to anti-
infl ammatory cytokines such as IL-4. 
Finally, in vitro studies have also dem-
onstrated that infl ammatory activated 
macrophages are capable of inducing 
cell death in mesangial and tubular 
cells.2
A range of macrophage depletion 
studies have also demonstrated that 
macrophages are responsible for injury 
in GN. Th e observation that whole-body 
radiation prevented the characteristic 
progressive glomerular infl ammation 
seen in a number of animal models, and 
that this coincided with a reduction in 
macrophage infi ltration, is supportive. 
Furthermore, in rat NTN, both an anti-
macrophage serum and cyclophospha-
mide-induced leukopenia improve renal 
injury.3 In cyclophosphamide-induced 
leukopenia, injury is restored after 
intravenous administration of a mac-
rophage cell line. In anti-Th y 1.1 GN, 
macrophage depletion using clodro-
nate liposomes led to an improvement 
of renal histology, although no changes 
in proteinuria were observed. By a sim-
ilar method of macrophage depletion, 
kidneys of rats were protected against 
ischemia–reperfusion injury, with re-
establishment of injury following mac-
rophage administration.4 Recent work 
has used a conditional macrophage 
ablation model to investigate the role 
of macrophages in progressive murine 
NTN. Macrophage depletion performed 
between days 15 and 20 reduced glomer-
ular crescent formation, tubular-cell 
apoptosis, interstitial fi brosis, and pro-
teinuria and improved renal function, 
thereby reinforcing a major injurious 
role for infi ltrating macrophages.5
Macrophage activation is also asso-
ciated with severity of renal injury in 
human disease. Rastaldi and colleagues 
have shown that in anti-neutrophil 
cytoplasmic antibody (ANCA)-posi-
tive vasculitis, macrophages in infl amed 
glomeruli were mainly TNF-α- and 
major histocompatibility complex class 
II-positive (synonymous with macro-
phage activation), whereas in cryoglob-
ulinemic vasculitis, less than 30% of 
macrophages were similarly activated.6 
Th us, diff erential macrophage activation 
may occur depending on the nature of 
the injury.
Modulation of the cytokine microenvi-
ronment
A range of studies in experimental renal 
disease have addressed the effect of 
inhibiting proinfl ammatory activation. 
Inhibition of IL-1β or TNF-α in NTN 
reduced injury and associated macro-
phage infi ltration. In line with this, anti-
TNF strategies have shown some value 
in the treatment of ANCA-associated 
systemic vasculitis with GN, although 
whether this alters macrophage func-
tion remains unclear.
With regard to anti-inflammatory 
cytokines, data support their ability to 
alter glomerular injury. IL-4 ameliorated 
acute crescentic GN when administered 
before or aft er disease initiation. Inter-
estingly, when administered aft er disease 
onset, IL-4 did not alter infi ltration of 
macrophages but did reduce their state 
of activation with attenuated inducible 
nitric oxide synthase and ED3 expres-
sion. Th is is an important observation, 
as it suggests that the phenotypic prop-
erties of macrophages are more impor-
tant than their absolute number. IL-10 
also has important anti-infl ammatory 
eff ects. Its administration is protective 
in murine NTN. Moreover, in lupus-
prone mice, defi ciency of IL-10 leads 
to more severe GN with IL-10 admin-
istration being protective. Long-term 
administration of IL-10 was achieved in 
rats by in vivo transduction with adeno-
associated virus expressing IL-10. Aft er 
a fi ve-sixths nephrectomy, these animals 
Figure 1 | Pro-resolution macrophages. A range of approaches can be used to modulate 
macrophage function, including viral transduction (adenovirus and lentivirus), treatment with 
steroids, or stimulation with cytokines. A number of properties are potentially beneficial, including 
production of anti-inflammatory cytokines, removal of apoptotic cells, degradation of matrix 
by matrix metalloproteinases (MMPs), and induction of T-cell anergy. IL, interleukin; IL-1ra, IL-1 
receptor antagonist; MHC, major histocompatibility complex; TCR, T-cell receptor.
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had improved renal function associated 
with reduced macrophage and T-cell 
infi ltration as compared with controls.
Pro-resolution properties of macro-
phages
The majority of data have focused on 
reducing macrophage activation to 
inhibit infl ammation, but, critically, mac-
rophages may also be involved in resolu-
tion of infl ammation (Figure 1). Removal 
of apoptotic cells, both infl ammatory and 
resident renal cells, is likely to be a key 
event in the resolution of renal infl am-
mation. Macrophages that have taken 
up apoptotic cells develop anti-infl am-
matory properties with reduced TNF-α, 
and increased IL-10 and transforming 
growth factor-β production. One eff ect 
of steroids is to increase macrophage 
phagocytosis of apoptotic cells. Macro-
phages can produce IL-10 on activation, 
and this may have a key role in regulating 
infl ammation.
Macrophages and dendritic cells are 
also involved in antigen presentation 
to T cells. Th is stimulates the immune 
response propagating injury. However, 
when antigen presentation occurs in 
the absence of appropriate antigen-pre-
senting cell costimulation, T-cell anergy 
results, and the immune response is 
inhibited. Blockade of T-cell costimula-
tion with CTLA4-IgG has been shown to 
inhibit the development of experimental 
GN. Macrophages may have a key role in 
the propagation of this eff ect.
Recent in vivo data support a pro-
resolution role for macrophages. In the 
liver, carbon tetrachloride (CCl4) induces 
fi brosis, which resolves on discontinua-
tion of the chemical. During the ini-
tiation of injury, macrophage depletion 
reduced collagen deposition. Conversely, 
when macrophages were depleted con-
currently with stopping CCl4, the resolu-
tion of fi brosis was delayed.7 Potentially, 
macrophages may have an important role 
in both the prevention and the resolution 
of renal scarring.
Macrophage therapy
Given the key role of macrophages in 
infl ammation, there has been interest 
in whether delivery of modifi ed mac-
rophages could infl uence the outcome 
of GN. This has been addressed by a 
number of groups. Yokoo and colleagues 
showed that systemic injection of macro-
phages transduced to express IL-1 recep-
tor antagonist reduced the severity of GN 
in mice with NTN and reduced intersti-
tial macrophage infi ltration in a model of 
unilateral ureteric obstruction.8 Injected 
macrophages could be identifi ed in renal 
tissue up to 4 weeks aft er injection.
Kluth and colleagues have shown that 
a macrophage cell line expressing rat IL-4 
localized effi  ciently to infl amed glomer-
uli of rats with NTN aft er direct injec-
tion into the renal artery and reduced 
macrophage infi ltration, GN, and pro-
teinuria for up to 7 days. In the same 
model, injection of primary cultures of 
rat bone marrow-derived macrophages 
transduced to express IL-10 similarly 
produced a marked reduction in albu-
minuria and macrophage activation.9 
Th ese authors also showed that injection 
of macrophages into a single kidney was 
able to dampen disease in the contral-
ateral kidney, an eff ect not mirrored by 
systemic injection of cells.
More recently, Wilson et al.10 have 
shown that injection of macrophages 
transduced with the IκB super-repres-
sor, which blocks nuclear factor-κB 
proinfl ammatory signaling, also blocks 
the development of GN. Inhibition of 
nuclear factor-κB signaling appeared to 
enhance IL-10 secretion. Th ese experi-
ments all show that injection of a popu-
lation of macrophages aft er the onset of 
disease is able to reduce the development 
of renal injury even when they represent 
only a small proportion of the localized 
infl ammatory cells.
Previous work has focused on viral 
transduction of bone marrow-derived 
macrophages, which has the benefi t of 
establishing expression of specifi c trans-
genes. Clearly this would have consid-
erable limitations for translational 
work. An alternative approach has 
been taken by Wang et al.1 Th ey have 
isolated murine splenic macrophages 
and stimulated them with IL-4/IL-13 
or with lipopolysaccharide. Th ese cells 
were injected on day 5 of adriamycin 
nephropathy and were identifi ed up to 
day 28 in the kidney. Th e presence of 
cells stimulated with IL-4/IL-13 resulted 
in reduced histological injury, improved 
serum creatinine, lower proteinuria, and 
reduced activation of infi ltrating mac-
rophages. IL-4/IL-13-stimulated cells 
maintained their phenotype in vitro for 
3 weeks, and this was marked particu-
larly by IL-10 expression.
Th us, macrophages are able to modu-
late renal infl ammation. Th ere remain, 
however, a number of unanswered ques-
tions. What are the mechanism and site 
of action of the modifi ed macrophages? 
Is this dependent on renal localization, 
or are there systemic effects? What 
modulation of macrophages is most 
eff ective, and will this be disease-spe-
cifi c? Overall, the study by Wang et al.1 
and other studies highlight the promise 
of using the pro-resolution properties 
of macrophages in the modulation of 
renal disease.
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